Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE161874 | GEO | 2021/12/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells [PLAC-seq]

Project description:Precision medicine depends critically on the development of treatment strategies that can specifically target cancer cells and have minimal adverse effects on normal cells. Cancer-cell-specific enhancers represent a class of therapeutic targets, however, a lack of comprehensive map of pro-growth enhancers in cancer cells presents a significant hurdle to this strategy. Here we address the knowledge gap by carrying out large-scale CRISPR-based perturbation screens to identify pro-growth enhancers in multiple cancer cell lines. We report the finding of 510 pro-growth enhancers, the majority of which show evidence of accessibility only in cancer cells but not in normal cell types. In addition, 16 pro-growth enhancers are selectively associated with poor clinical outcomes in colorectal cancer. These cancer cell specific pro-growth enhancers are modulated by lineage-specific transcription factors acting downstream of signaling pathways, and could be pharmacologically targeted in specific cancer cell types. Our results not only uncover the molecular mechanism governing the function of cancer cell-specific pro-growth enhancers but also reveal novel therapeutic targets for cancer treatment.

2021-12-31 | GSE161873 | GEO

Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells [ChIP-Seq]

2021-12-31 | GSE161871 | GEO

Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells

Project description:Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells

| PRJNA679750 | ENA

Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells [PLAC-seq]

Project description:Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells [PLAC-seq]

| PRJNA679753 | ENA

Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells [ChIP-Seq]

Project description:Systematic Discovery and Therapeutic Targeting of Pro-growth Enhancers in Human Cancer Cells [ChIP-Seq]

| PRJNA679752 | ENA

Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-04-25 | E-GEOD-55064 | biostudies-arrayexpress

Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment.

Project description:Super-enhancers (SEs) refer to large clusters of enhancers that drive gene expressions. Recent data has provided novel insights in elucidating the roles of SEs in many diseases, including cancer. Many mechanisms involved in tumorigenesis and progression, ranging from internal gene mutation and rearrangement to external damage and inducement, have been demonstrated to be highly associated with SEs. Moreover, translocation, formation, deletion, or duplication of SEs themselves could lead to tumor development. It has been reported that various oncogenic molecules and pathways are tightly regulated by SEs. Moreover, several clinical trials on novel SEs blockers, such as BET inhibitor and CDK7i, have indicated the potential roles of SEs in cancer therapy. In this review, we highlighted the underlying mechanism of action of SEs in cancer development and the corresponding novel potential therapeutic strategies. It is speculated that targeting SEs could complement the traditional approaches and lead to more effective treatment for cancer patients.

| S-EPMC6499164 | biostudies-literature

Targeting H3K4 methylation as a therapeutic strategy for Huntington's disease

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-07-18 | E-GEOD-48963 | biostudies-arrayexpress